Navigation Links
Robust Biopharmaceutical Pipeline Offers New Hope for Patients
Date:1/17/2013

WASHINGTON, Jan. 17, 2013 /PRNewswire-USNewswire/ -- The biopharmaceutical pipeline is innovative and robust, with a high proportion of potential first-in-class medicines and therapies targeting diseases with limited treatment options, according to a new report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA). 

(Logo: http://photos.prnewswire.com/prnh/20091027/PHRMALOGO)

Watch PhRMA's live webinar about the report today at 12:00 pm EST.

The report, developed by the Analysis Group and supported by PhRMA, reveals that more than 5,000 new medicines are in the pipeline globally. Of these medicines in various phases of clinical development, 70 percent are potential first-in-class medicines, which could provide exciting new approaches to treating disease for patients.

"Biopharmaceutical companies, working with other partners in the American research ecosystem, have made incredible progress in helping confront some of the most challenging and costly diseases facing patients around the world," said John J. Castellani , president and CEO, PhRMA.  "With more than 5,000 medicines in development for patients suffering from a wide range of diseases, there is a palpable excitement around the biopharmaceutical pipeline and the future opportunities for new, cutting-edge medicines to improve patient care and bring value to the entire U.S. health care system." 

Many of the new medicines in the pipeline are also for diseases for which no new therapies have been approved in the last decade.  For example, there are 158 potential medicines for ovarian cancer, 19 for sickle cell disease and 41 for small cell lung cancer.

Additionally, among other data in the report, the authors found that personalized medicines account
'/>"/>

SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neurostimulation Devices Market to 2018 - Technological Advances and Robust Pipeline with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth
2. Frost & Sullivan Lauds U-Systems for Its Unique Technology and Strategic Excellence Paving the Way for Robust Growth
3. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
4. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
5. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
6. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
7. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
8. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
9. Inspiration Biopharmaceuticals Announces Clinical Hold of Clinical Trials Evaluating IB1001 for the Treatment and Prevention of Bleeding in Hemophilia B
10. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
11. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Mar. 04, 2015 Research and Markets ... of the "Negative Pressure Wound Therapy Market ... Industry Analysis, Size, Share, Growth, Trends and Forecast ... , The global negative pressure ... and by geography. By product types the NPWT ...
(Date:3/4/2015)... 4, 2015  ECR Booth #317/Expo C - Varian ... a full spectrum of X-ray imaging solutions that bundle ... and enable greater patient throughput for manufacturers of mammography, ... solutions are on display at the Annual European Congress ... this week.   "This year,s ...
(Date:3/4/2015)... 2015  Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY ... commercialization of proprietary compounded drug therapies, today reported that ... 2014 financial results on Thursday, March 12, 2015.  The ... EDT (1:30 p.m. PDT) on the same day to ... activities.  The conference call and webcast will be open ...
Breaking Medicine Technology:Global Negative Pressure Wound Therapy (Conventional and Single Use NPWT Systems) Market Report 2014-2020 2Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 2Varian Medical Systems to Showcase New X-Ray Imaging Components at the European Congress of Radiology (ECR) Annual Meeting 3Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2014 Financial Report Conference Call and Webcast on March 12, 2015 at 4:30 p.m. EDT 2Imprimis Pharmaceuticals to Host its Fourth Quarter and Fiscal Year 2014 Financial Report Conference Call and Webcast on March 12, 2015 at 4:30 p.m. EDT 3
... 6, 2011 Actavis, an international generic pharmaceuticals ... approval from the US Food & Drug Administration ... mg CIV.  Distribution of the product has commenced. ... to launch Zolpidem Tartrate Extended-Release Tablets 6.25 mg strength ...
... June 6, 2011 Brainlab announced today ... acquire Voyant Health. Voyant Health,s core technology, ... and to plan and digitally template surgical procedures from ... the operating room (OR). Another key technology is VoyantLink™, ...
Cached Medicine Technology:Actavis Receives FDA Approval of Zolpidem Tartrate Extended-Release Tablets USP, 12.5 mg CIV in the U.S. 2Brainlab Acquires Voyant Health 2Brainlab Acquires Voyant Health 3
(Date:3/4/2015)... Estates, CA (PRWEB) March 04, 2015 ... clever dialogue and lyrical music, will be performed by ... Rolling Hills Estates, CA, this March 6-22, 2015, on ... Arts Center at Peninsula High School (27118 Silver ... available one hour before the program or may be ...
(Date:3/4/2015)... March 04, 2015 The report ... client survey, marketing channels, industry development trend and ... the industry, including spices definitions, applications and industry ... market analysis are provided with a focus on ... market. A comparison between the international and Chinese ...
(Date:3/4/2015)... 04, 2015 Information Innovators Inc ... Dvorak has joined the company as Chief Technology ... technology focus for the company, including customer-centric strategies and ... 20 years of experience as a technology executive and ... roles at the FBI including oversight of enterprise data ...
(Date:3/4/2015)... BC (PRWEB) March 04, 2015 According ... , millions of people in the U.S. suffer from ... reflux. Medications are commonly prescribed to control acid production, ... surgical procedures can overly correct the problem and lead ... Market Opportunity, GERD occurs when the lower esophageal sphincter ...
(Date:3/4/2015)... Florida and Dayton, Ohio (PRWEB) March 04, 2015 ... nearly killed in an IED explosion in Iraq, tells ... while recovering. He received some free Chiropractic care from ... to Magnetic Resonance Therapy. , This is what Harris ... using the Magnesphere, I have clarity, I feel more ...
Breaking Medicine News(10 mins):Health News:The New Mel Brooks Musical Young Frankenstein Performance March 6-March 22, 2015, by the Award Winning Drama Department at Peninsula High School, Rolling Hills 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 3Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 2Health News:Information Innovators Inc. Announces Mr. John Dvorak as the New Chief Technology Officer 3Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 3Health News:Decorated Veterans Endorse “Halos for Heroes” an Indiegogo campaign to Help Wounded Military Heal at Home 2Health News:Decorated Veterans Endorse “Halos for Heroes” an Indiegogo campaign to Help Wounded Military Heal at Home 3
... of Pharmaceutical Marketing Industry Due to New PhRMA ... 6 Pharmaceutical marketers are taking on the ... Systems, a unique marketing company whose integrated engagement ... the sector. In the past two years the ...
... A survey recently conducted by the Society of ... Compliance Association (HCCA) reveals that the declining economy may ... in business. In addition, this increased risk is ... risks are expected to at best hold steady, if ...
... /PRNewswire/ -- Akerman Senterfitt, one of the ... top 100 firms in the U.S., today announced that ... the auspices of the American Health Lawyers Association (AHLA) ... and issues concerning privilege and confidentiality. The live audiocast ...
... POINT, N.Y., Jan. 6 Akrimax Pharmaceuticals, LLC ... of pharmaceutical products for a global company beginning ... partners in a competitive process.Akrimax President Alan L. ... to acquire the Rouses Point facility which possesses ...
... KENILWORTH, N.J., Jan. 6 Schering-Plough Corporation (NYSE: ... results for the 2008 fourth quarter and full year on ... that day, Schering-Plough will conduct a conference call to review ... Fred Hassan, Schering-Plough,s chairman and CEO, and other members of ...
... for expanding role of patient flow automation PITTSBURGH, Jan. ... its clients, now more than 700 hospitals, solve their ... to increase capacity and improve patient flow is now ... have postponed building and expansion plans because of the ...
Cached Medicine News:Health News:Kyp Systems Takes on the Challenge of New Pharmaceutical Marketing Guidelines 2Health News:Kyp Systems Takes on the Challenge of New Pharmaceutical Marketing Guidelines 3Health News:Legal and Ethical Violations Risks Seen Rising, But Not Resources to Control the Risk 2Health News:Legal and Ethical Violations Risks Seen Rising, But Not Resources to Control the Risk 3Health News:Akerman Senterfitt Hosts National Panel Discussion on Patient Safety Organizations 2Health News:Akerman Senterfitt Hosts National Panel Discussion on Patient Safety Organizations 3Health News:Akrimax Pharmaceuticals Announces Manufacturing Partnership 2Health News:Schering-Plough Schedules Conference Call and Webcast for 2008 Fourth Quarter and Full Year Earnings 2Health News:TeleTracking Technologies to Focus on Growth 2Health News:TeleTracking Technologies to Focus on Growth 3
... four channel platelet aggregation profiler combined with ... conjunction with Microsoft WindowsTM, the PAP-4CD has ... automatic storage of test results, plus simplified ... modes are available: chromogenic assays, von willebrand ...
... 400 plus, innovation means 4 on-board ... cuvettes and im-proved operator ergonomics. This ... ease-of-use required for true workload consolidation, ... with only one analytical platform, one ...
... The Advia 2400 ... sample volume (as low ... water consumption (40 L/hour) ... The optional universal rack ...
Iron FS Ferene for determination of iron in serum. Available with Calibrator: Trucal U and Controls: Trulab N, Trulab P. For automated systems....
Medicine Products: